We are live on ! Find out more
SCM

Segantii Capital Management Portfolio holdings

AUM $1.54B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
-5.51%
1 Year Est. Return
+16.73%
3 Year Est. Return
+33.11%
5 Year Est. Return
+149.98%
10 Year Est. Return
+416.67%
AUM
$3.09B
AUM Growth
-$392M
Cap. Flow
-$593M
Cap. Flow %
-19.17%
Top 10 Hldgs %
52.08%
Holding
665
New
159
Increased
25
Reduced
41
Closed
161

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.59%
2 Technology 12.13%
3 Financials 11.13%
4 Communication Services 10.36%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSTD
301
DELISTED
Northern Star Investment Corp. IV
NSTD
$490K 0.02%
50,000
JUGG
302
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
$490K 0.02%
+50,000
New +$488K
LEGAW
303
DELISTED
Lead Edge Growth Opportunities, Ltd Warrant
LEGAW
$490K 0.02%
+50,000
New +$45.2K
GSAQW
304
DELISTED
Global Synergy Acquisition Corp. Warrant
GSAQW
$490K 0.02%
50,000
GSQB
305
DELISTED
G Squared Ascend II Inc.
GSQB
$489K 0.02%
+50,000
New +$487K
MSDA
306
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
$489K 0.02%
50,000
TSPQ
307
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
$489K 0.02%
50,000
EPWR
308
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$489K 0.02%
50,000
FSSIW
309
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$489K 0.02%
50,000
SWETW
310
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$489K 0.02%
50,000
EQHA.WS
311
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$489K 0.02%
50,000
AEON icon
312
AEON Biopharma
AEON
$13.6M
$488K 0.02%
+694
New +$485K
LDTCW
313
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$488K 0.02%
+50,000
New +$41.7K
ANAC
314
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$488K 0.02%
50,000
HCII
315
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$488K 0.02%
50,000
ZWRK
316
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
$488K 0.02%
50,100
JOBS
317
DELISTED
51job Inc
JOBS
$488K 0.02%
7,018
-8,289
-54% -$610K
BTMD icon
318
Biote Corp
BTMD
$46.7M
$487K 0.02%
50,000
AAC.WS
319
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$487K 0.02%
50,000
NSTC
320
DELISTED
Northern Star Investment Corp. III
NSTC
$487K 0.02%
50,000
HCNE
321
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
$487K 0.02%
+50,000
New +$486K
KSI
322
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$487K 0.02%
50,000
HERAW
323
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$487K 0.02%
50,000
DNZ.WS
324
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$487K 0.02%
50,000
AKICW
325
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
$487K 0.02%
50,000

Similar funds

Segantii Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Segantii Capital Management held 665 positions worth $3.09B, down 11% from $3.48B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Segantii Capital Management withdrew a net $593M in Q3 2021, closing 161 positions and reducing 41 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $142M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Segantii Capital Management opened a new position in FIVE9 worth $135M.

  • Segantii Capital Management's largest Q3 2021 buy was FIVE9: 842,999 shares worth $135M.
  • Segantii Capital Management added most to Alibaba in Q3 2021, an estimated $256M increase.
  • Segantii Capital Management's biggest Q3 2021 reduction was Trip.com Group, cutting an estimated $75.5M.
  • Segantii Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $142M.
  • Segantii Capital Management's ten largest holdings make up 52% of its $3.09B portfolio in Q3 2021.
  • Segantii Capital Management opened 159 new positions and closed 161 in Q3 2021.
  • Segantii Capital Management's portfolio value fell 11% quarter-over-quarter to $3.09B.

Based on Segantii Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.